Combined with the findings that the CORO1C, RAD23B, and ARPC5 concentrations in urine show good performance in distinguishing early-stage CRC (stage 0 and stage I) from HCs, these findings strongly suggest alterations in urinary proteins may occur at the tumor initiation stage. This evidence concerns the gene ARPC5 and colorectal carcinoma.